BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15181093)

  • 1. Type II gonadotropin-releasing hormone stimulates p38 mitogen-activated protein kinase and apoptosis in ovarian cancer cells.
    Kim KY; Choi KC; Park SH; Chou CS; Auersperg N; Leung PC
    J Clin Endocrinol Metab; 2004 Jun; 89(6):3020-6. PubMed ID: 15181093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular signal-regulated protein kinase, but not c-Jun N-terminal kinase, is activated by type II gonadotropin-releasing hormone involved in the inhibition of ovarian cancer cell proliferation.
    Kim KY; Choi KC; Park SH; Auersperg N; Leung PC
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1670-7. PubMed ID: 15598681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone type II induces apoptosis of human endometrial cancer cells by activating GADD45alpha.
    Wu HM; Cheng JC; Wang HS; Huang HY; MacCalman CD; Leung PC
    Cancer Res; 2009 May; 69(10):4202-8. PubMed ID: 19366794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of gonadotropin-releasing hormone (GnRH)-I and -II-induced cell growth inhibition in ovarian cancer cells: role of the GnRH-I receptor and protein kinase C pathway.
    Kim KY; Choi KC; Auersperg N; Leung PC
    Endocr Relat Cancer; 2006 Mar; 13(1):211-20. PubMed ID: 16601289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GnRH-II antagonists induce apoptosis in human endometrial, ovarian, and breast cancer cells via activation of stress-induced MAPKs p38 and JNK and proapoptotic protein Bax.
    Fister S; Günthert AR; Aicher B; Paulini KW; Emons G; Gründker C
    Cancer Res; 2009 Aug; 69(16):6473-81. PubMed ID: 19638591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.
    Park DW; Choi KC; MacCalman CD; Leung PC
    Reprod Biol Endocrinol; 2009 Aug; 7():81. PubMed ID: 19656390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
    Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
    J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the p38 mitogen-activated protein kinase pathway by gonadotropin-releasing hormone.
    Roberson MS; Zhang T; Li HL; Mulvaney JM
    Endocrinology; 1999 Mar; 140(3):1310-8. PubMed ID: 10067858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter.
    Bonfil D; Chuderland D; Kraus S; Shahbazian D; Friedberg I; Seger R; Naor Z
    Endocrinology; 2004 May; 145(5):2228-44. PubMed ID: 14736735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SB203580 reverses adrenomedullin's effect on proliferation and apoptosis in cultured mesangial cells.
    Parameswaran N; Spielman WS; Brooks DP; Nambi P
    Eur J Pharmacol; 1999 Apr; 371(1):75-82. PubMed ID: 10355597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mitogen-activated protein kinase/extracellular signal-regulated kinase cascade in gonadotropin-releasing hormone-induced growth inhibition of a human ovarian cancer cell line.
    Kimura A; Ohmichi M; Kurachi H; Ikegami H; Hayakawa J; Tasaka K; Kanda Y; Nishio Y; Jikihara H; Matsuura N; Murata Y
    Cancer Res; 1999 Oct; 59(20):5133-42. PubMed ID: 10537288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [P38 mitogen-activated protein kinase mediates glucocorticoid receptor function induced by dexamethasone in acute lymphoblastic leukemia cells].
    He L; Li D; Hou KZ; Liu YP
    Zhonghua Er Ke Za Zhi; 2007 Sep; 45(9):687-91. PubMed ID: 18021564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer.
    Gründker C; Emons G
    Reprod Biol Endocrinol; 2003 Oct; 1():65. PubMed ID: 14594454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells.
    Seidman R; Gitelman I; Sagi O; Horwitz SB; Wolfson M
    Exp Cell Res; 2001 Aug; 268(1):84-92. PubMed ID: 11461121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen inhibits cell proliferation via mitogen-activated protein kinase cascades in human ovarian cancer cell lines in a manner not dependent on the expression of estrogen receptor or the sensitivity to cisplatin.
    Mabuchi S; Ohmichi M; Kimura A; Ikebuchi Y; Hisamoto K; Arimoto-Ishida E; Nishio Y; Takahashi K; Tasaka K; Murata Y
    Endocrinology; 2004 Mar; 145(3):1302-13. PubMed ID: 14645110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone induces apoptosis of prostate cancer cells: role of c-Jun NH2-terminal kinase, protein kinase B, and extracellular signal-regulated kinase pathways.
    Kraus S; Levy G; Hanoch T; Naor Z; Seger R
    Cancer Res; 2004 Aug; 64(16):5736-44. PubMed ID: 15313914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic changes in mitogen-activated protein kinase (MAPK) activities in the corpus luteum of the bonnet monkey (Macaca radiata) during development, induced luteolysis, and simulated early pregnancy: a role for p38 MAPK in the regulation of luteal function.
    Yadav VK; Medhamurthy R
    Endocrinology; 2006 Apr; 147(4):2018-27. PubMed ID: 16410301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium.
    Chuang SM; Wang IC; Yang JL
    Carcinogenesis; 2000 Jul; 21(7):1423-32. PubMed ID: 10874022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell growth of ovarian cancer cells is stimulated by xenoestrogens through an estrogen-dependent pathway, but their stimulation of cell growth appears not to be involved in the activation of the mitogen-activated protein kinases ERK-1 and p38.
    Park SH; Kim KY; An BS; Choi JH; Jeung EB; Leung PC; Choi KC
    J Reprod Dev; 2009 Feb; 55(1):23-9. PubMed ID: 18854640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone activates mitogen-activated protein kinase in human ovarian and placental cells.
    Kang SK; Tai CJ; Cheng KW; Leung PC
    Mol Cell Endocrinol; 2000 Dec; 170(1-2):143-51. PubMed ID: 11162898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.